Veronica MacLeod

3.1k total citations · 1 hit paper
19 papers, 2.6k citations indexed

About

Veronica MacLeod is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Veronica MacLeod has authored 19 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cell Biology and 6 papers in Oncology. Recurrent topics in Veronica MacLeod's work include Proteoglycans and glycosaminoglycans research (10 papers), Glycosylation and Glycoproteins Research (6 papers) and Multiple Myeloma Research and Treatments (6 papers). Veronica MacLeod is often cited by papers focused on Proteoglycans and glycosaminoglycans research (10 papers), Glycosylation and Glycoproteins Research (6 papers) and Multiple Myeloma Research and Treatments (6 papers). Veronica MacLeod collaborates with scholars based in United States, United Kingdom and Sweden. Veronica MacLeod's co-authors include W. Sue T. Griffin, Laura Stanley, C.A. Araoz, Lon R. White, Linda J. Perrot, Charles L. White, Ling Chen, Ralph D. Sanderson, Yang Yang and Thomas J. Kelly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Veronica MacLeod

19 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

1989 1.5k citations W. Sue T. Griffin, Laura Stanley et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Veronica MacLeod United States	13	1.4k	797	719	717	323	19	2.6k
Alban Gaultier United States	31	1.4k 1.1×	378 0.5×	357 0.5×	348 0.5×	458 1.4×	54	2.8k
Fernando A. González Spain	30	2.1k 1.5×	356 0.4×	305 0.4×	335 0.5×	336 1.0×	104	3.8k
Shalina S. Ousman Canada	21	1.0k 0.8×	358 0.4×	728 1.0×	179 0.2×	748 2.3×	40	2.8k
Joel S. Pachter United States	39	1.5k 1.1×	391 0.5×	1.3k 1.8×	640 0.9×	680 2.1×	76	3.7k
María‐Paz Marzolo Chile	31	1.3k 1.0×	712 0.9×	204 0.3×	847 1.2×	212 0.7×	55	2.7k
Justin P. Rubio Australia	28	778 0.6×	446 0.6×	399 0.6×	117 0.2×	528 1.6×	60	2.7k
Winnie S. Liang United States	30	2.3k 1.7×	1.3k 1.6×	573 0.8×	125 0.2×	257 0.8×	82	4.0k
Joo‐Ho Shin South Korea	26	2.1k 1.5×	666 0.8×	355 0.5×	386 0.5×	186 0.6×	74	3.7k
Hiroaki Asou Japan	34	1.6k 1.2×	275 0.3×	435 0.6×	530 0.7×	507 1.6×	126	3.4k
Masayuki Kaneko Japan	33	1.6k 1.2×	623 0.8×	145 0.2×	1.6k 2.3×	329 1.0×	98	3.6k

Countries citing papers authored by Veronica MacLeod

Since Specialization

Citations

This map shows the geographic impact of Veronica MacLeod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica MacLeod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica MacLeod more than expected).

Fields of papers citing papers by Veronica MacLeod

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica MacLeod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica MacLeod. The network helps show where Veronica MacLeod may publish in the future.

Co-authorship network of co-authors of Veronica MacLeod

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica MacLeod. A scholar is included among the top collaborators of Veronica MacLeod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica MacLeod. Veronica MacLeod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Garg, Tarun K., Priyangi A. Malaviarachchi, Veronica MacLeod, et al.. (2016). Myeloma-Derived Exosomes and Soluble Factors Suppress Natural Killer Cell Function. Blood. 128(22). 2066–2066. 7 indexed citations

Pawlyn, Charlotte, Martin Kaiser, Joshua Epstein, et al.. (2015). Abstract 3516: EZH2 overexpression in myeloma patients shortens survival and in-vitro data supports a potential new targeted treatment strategy. Cancer Research. 75(15_Supplement). 3516–3516. 2 indexed citations

Sifford, Jeffrey M., et al.. (2013). Phosphoproteomic Analyses Reveal Signaling Pathways That Facilitate Lytic Gammaherpesvirus Replication. PLoS Pathogens. 9(9). e1003583–e1003583. 22 indexed citations

Garg, Tarun K., Ricky D. Edmondson, Junaid Khan, et al.. (2013). Multiple Myeloma Cells Modulate ICAM-3 To Evade Natural Killer Cell-Mediated Lysis. Blood. 122(21). 3105–3105. 1 indexed citations

Paden, Clinton R., Shweta S. Chavan, Veronica MacLeod, et al.. (2012). Amplification of JNK Signaling Is Necessary To Complete the Murine Gammaherpesvirus 68 Lytic Replication Cycle. Journal of Virology. 86(24). 13253–13262. 20 indexed citations

Dai, Yuemeng, et al.. (2011). Ribosomal Protein Metallopanstimulin-1 Impairs Multiple Myeloma CAG Cells Growth and Inhibits Fibroblast Growth Factor Receptor 3. Clinical Lymphoma Myeloma & Leukemia. 11(6). 490–497. 6 indexed citations

Kelly, Thomas J., Larry J. Suva, Kristy M. Nicks, Veronica MacLeod, & Ralph D. Sanderson. (2010). Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis. Journal of Bone and Mineral Research. 25(6). 1295–1304. 32 indexed citations

Khotskaya, Yekaterina B., Yuemeng Dai, Veronica MacLeod, et al.. (2009). Syndecan-1 Is Required for Robust Growth, Vascularization, and Metastasis of Myeloma Tumors in Vivo. Journal of Biological Chemistry. 284(38). 26085–26095. 78 indexed citations

Yang, Yang, Veronica MacLeod, Hua‐Quan Miao, et al.. (2007). Heparanase Enhances Syndecan-1 Shedding. Journal of Biological Chemistry. 282(18). 13326–13333. 230 indexed citations

10.

Yang, Yang, Veronica MacLeod, Yuemeng Dai, et al.. (2007). The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. Blood. 110(6). 2041–2048. 105 indexed citations

11.

Dai, Yuemeng, Yang Yang, Veronica MacLeod, et al.. (2005). HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor Growth in Vivo. Journal of Biological Chemistry. 280(48). 40066–40073. 122 indexed citations

12.

Sanderson, Ralph D., Yang Yang, Thomas J. Kelly, et al.. (2005). Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: Growth regulation and the prospect of new cancer therapies. Journal of Cellular Biochemistry. 96(5). 897–905. 125 indexed citations

13.

Kelly, Thomas J., Larry J. Suva, Yan Huang, et al.. (2005). Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases. Cancer Research. 65(13). 5778–5784. 77 indexed citations

14.

Yang, Yang, Veronica MacLeod, Manali Bendre, et al.. (2004). Heparanase Promotes the Spontaneous Metastasis of Myeloma Cells to Bone.. Blood. 104(11). 635–635. 1 indexed citations

15.

Yang, Yang, Veronica MacLeod, Manali Bendre, et al.. (2004). Heparanase promotes the spontaneous metastasis of myeloma cells to bone. Blood. 105(3). 1303–1309. 115 indexed citations

16.

Kelly, Thomas J., Hua‐Quan Miao, Yang Yang, et al.. (2003). High heparanase activity in multiple myeloma is associated with elevated microvessel density.. PubMed. 63(24). 8749–56. 146 indexed citations

17.

Lolait, Stephen J., Michael Brownstein, Noboru Saito, et al.. (2000). Molecular Cloning and Functional Characterization of a Vasotocin Receptor Subtype That Is Expressed in the Shell Gland and Brain of the Domestic Chicken1. Biology of Reproduction. 62(1). 8–15. 52 indexed citations

18.

Jones, Stacie M., et al.. (1997). Evidence for Alternative Splicing in Hepatic α_1B-Adrenergic Receptor Gene Expression. Journal of Receptors and Signal Transduction. 17(6). 815–832. 1 indexed citations

19.

Griffin, W. Sue T., Laura Stanley, Ling Chen, et al.. (1989). Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.. Proceedings of the National Academy of Sciences. 86(19). 7611–7615. 1506 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact